A. L. Ordoñez-Vázquez

Cross-sectional pilot study to assess primary healthcare workers’ knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico

N. Chavez-Tapia, M. Uribe, Paulina Vidal-Cevallos, 2021, Scientific reports.

Editorial: Treatment with Dual Incretin Receptor Agonists to Maintain Normal Glucose Levels May Also Maintain Normal Weight and Control Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

N. Méndez-Sánchez, Shreya C Pal, A. L. Ordoñez-Vázquez, 2022, Medical science monitor : international medical journal of experimental and clinical research.

Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients

M. Uribe, G. Castro-Narro, E. Juárez-Hernández, 2022, International journal of environmental research and public health.

Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma

N. Chavez-Tapia, M. Uribe, N. Nuño-Lámbarri, 2022, Journal of hepatocellular carcinoma.

Current Therapies for Cholestatic Diseases

N. Méndez-Sánchez, C. Coronel-Castillo, A. L. Ordoñez-Vázquez, 2023, Biomedicines.